Abbott Laboratories Appoints New Board Member and Adopts New Incentive Stock Program

Details

The new program allows Abbott to grant various equity-based awards to its directors and employees. Additionally, Abbott's Board amended the bylaws to increase the board size to thirteen members. Shareholders also approved the appointment of Ernst & Young LLP as Abbott's auditors, the compensation of named executive officers, and the new incentive stock program and employee stock purchase plan for non-U.S. employees.

Items reported

About Abbott Laboratories

Abbott Laboratories, a globally renowned company, specializes in the development and production of healthcare and medical products. Founded in 1888 and headquartered in Abbott Park, Illinois, Abbott is a pivotal entity in the healthcare sector. The company provides essential products spanning diagnostics, medical devices, nutritional products, and branded generic pharmaceuticals. Notably, Abbott's extensive diagnostic solutions include immunoassays and molecular diagnostics, crucial for medical testing and healthcare management. Its medical devices division produces cardiovascular and neuromodulation products, enhancing patient care across diverse medical practices. Abbott’s nutritional segment, featuring well-known brands like Similac and Ensure, supports health and wellness across various demographics. Serving markets globally, Abbott Laboratories plays a critical role in advancing healthcare infrastructure and delivering innovative solutions that address evolving health challenges worldwide. As a significant player in the life sciences field, Abbott's contributions significantly influence patient outcomes and healthcare delivery systems.